PR Newswire BiotechOriginal article
Kedrion: en ESID 2026, los expertos piden un diagnóstico más temprano de las inmunodeficiencias secundarias
ConferenceNeutral
AI Analysis
Summary
Kedrion presented at ESID 2026 conference on the need for earlier diagnosis of secondary immunodeficiencies, highlighting their clinical significance amid increased use of immunosuppressive and biologic therapies.
Importance:3/10
Sentiment:
0.00
immunodeficiencysecondary immunodeficienciesdiagnosisESID 2026conference
Read the original article
Published by PR Newswire Biotech on October 14, 2026 5:31 PM
